Raymond James & Associates’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $44.8K | Sell |
11,731
-2,121
| -15% | -$8.1K | ﹤0.01% | 3821 |
|
|
2024
Q2 | $40.6K | Hold |
13,852
| – | – | ﹤0.01% | 3772 |
|
|
2024
Q1 | $54.9K | Sell |
13,852
-10,509
| -43% | -$41.6K | ﹤0.01% | 3756 |
|
|
2023
Q4 | $121K | Hold |
24,361
| – | – | ﹤0.01% | 3588 |
|
|
2023
Q3 | $123K | Buy |
+24,361
| New | +$123K | ﹤0.01% | 3538 |
|
|
2016
Q3 | – | Sell |
-1,154
| Closed | -$233K | – | 3120 |
|
|
2016
Q2 | $233K | Buy |
+1,154
| New | +$233K | ﹤0.01% | 2558 |
|